173 related articles for article (PubMed ID: 35399214)
1. Characterization of furathiocarb metabolism in in-vitro human liver microsomes and recombinant cytochrome P450 enzymes.
Abass K; Reponen P; Alsanie WF; Rautio A; Pelkonen O
Toxicol Rep; 2022; 9():679-689. PubMed ID: 35399214
[TBL] [Abstract][Full Text] [Related]
2. Metabolic profiling and
Abass K; Reponen P; Alsanie WF; Rautio A; Pelkonen O
Toxicol Rep; 2022; 9():750-758. PubMed ID: 36518466
[TBL] [Abstract][Full Text] [Related]
3. Metabolism of carbosulfan. I. Species differences in the in vitro biotransformation by mammalian hepatic microsomes including human.
Abass K; Reponen P; Mattila S; Pelkonen O
Chem Biol Interact; 2009 Oct; 181(2):210-9. PubMed ID: 19523935
[TBL] [Abstract][Full Text] [Related]
4. In vitro metabolism of carbofuran by human, mouse, and rat cytochrome P450 and interactions with chlorpyrifos, testosterone, and estradiol.
Usmani KA; Hodgson E; Rose RL
Chem Biol Interact; 2004 Dec; 150(3):221-32. PubMed ID: 15560889
[TBL] [Abstract][Full Text] [Related]
5. Metabolism of carbosulfan II. Human interindividual variability in its in vitro hepatic biotransformation and the identification of the cytochrome P450 isoforms involved.
Abass K; Reponen P; Mattila S; Pelkonen O
Chem Biol Interact; 2010 May; 185(3):163-73. PubMed ID: 20307514
[TBL] [Abstract][Full Text] [Related]
6. Inter-species differences between humans and other mammals in the in vitro metabolism of carbofuran and the role of human CYP enzymes.
Abass K; Reponen P; Anyanwu B; Pelkonen O
Environ Toxicol Pharmacol; 2023 Sep; 102():104243. PubMed ID: 37572996
[TBL] [Abstract][Full Text] [Related]
7. Human variation and CYP enzyme contribution in benfuracarb metabolism in human in vitro hepatic models.
Abass K; Reponen P; Mattila S; Rautio A; Pelkonen O
Toxicol Lett; 2014 Jan; 224(2):300-9. PubMed ID: 24016712
[TBL] [Abstract][Full Text] [Related]
8. Different contributions of cytochrome P450 2C19 and 3A4 in the oxidation of omeprazole by human liver microsomes: effects of contents of these two forms in individual human samples.
Yamazaki H; Inoue K; Shaw PM; Checovich WJ; Guengerich FP; Shimada T
J Pharmacol Exp Ther; 1997 Nov; 283(2):434-42. PubMed ID: 9353355
[TBL] [Abstract][Full Text] [Related]
9. Identification of the human P-450 enzymes responsible for the sulfoxidation and thiono-oxidation of diethyldithiocarbamate methyl ester: role of P-450 enzymes in disulfiram bioactivation.
Madan A; Parkinson A; Faiman MD
Alcohol Clin Exp Res; 1998 Sep; 22(6):1212-9. PubMed ID: 9756035
[TBL] [Abstract][Full Text] [Related]
10. Dermal pharmacokinetics of the insecticide furathiocarb in rats.
Liu KH; Sung HJ; Lee HK; Song BH; Ihm YB; Kim K; Lee HS; Kim JH
Pest Manag Sci; 2002 Jan; 58(1):57-62. PubMed ID: 11838286
[TBL] [Abstract][Full Text] [Related]
11. Identification of the human and rat P450 enzymes responsible for the sulfoxidation of S-methyl N,N-diethylthiolcarbamate (DETC-ME). The terminal step in the bioactivation of disulfiram.
Madan A; Parkinson A; Faiman MD
Drug Metab Dispos; 1995 Oct; 23(10):1153-62. PubMed ID: 8654205
[TBL] [Abstract][Full Text] [Related]
12. Identification of cytochrome P450 enzymes responsible for metabolism of cannabidiol by human liver microsomes.
Jiang R; Yamaori S; Takeda S; Yamamoto I; Watanabe K
Life Sci; 2011 Aug; 89(5-6):165-70. PubMed ID: 21704641
[TBL] [Abstract][Full Text] [Related]
13. In vitro identification of metabolic pathways and cytochrome P450 enzymes involved in the metabolism of etoperidone.
Yan Z; Caldwell GW; Wu WN; McKown LA; Rafferty B; Jones W; Masucci JA
Xenobiotica; 2002 Nov; 32(11):949-62. PubMed ID: 12487725
[TBL] [Abstract][Full Text] [Related]
14. Metabolic characterization of (1-(5-fluoropentyl)-1H-indol-3-yl)(4-methyl-1-naphthalenyl)-methanone (MAM-2201) using human liver microsomes and cDNA-overexpressed cytochrome P450 enzymes.
Kong TY; Kim JH; Choi WG; Lee JY; Kim HS; Kim JY; In MK; Lee HS
Anal Bioanal Chem; 2017 Feb; 409(6):1667-1680. PubMed ID: 27924364
[TBL] [Abstract][Full Text] [Related]
15. Metabolism of 7-benzyloxy-4-trifluoromethyl-coumarin by human hepatic cytochrome P450 isoforms.
Renwick AB; Surry D; Price RJ; Lake BG; Evans DC
Xenobiotica; 2000 Oct; 30(10):955-69. PubMed ID: 11315104
[TBL] [Abstract][Full Text] [Related]
16. CYP2B6, CYP3A4, and CYP2C19 are responsible for the in vitro N-demethylation of meperidine in human liver microsomes.
Ramírez J; Innocenti F; Schuetz EG; Flockhart DA; Relling MV; Santucci R; Ratain MJ
Drug Metab Dispos; 2004 Sep; 32(9):930-6. PubMed ID: 15319333
[TBL] [Abstract][Full Text] [Related]
17. In vitro metabolism of simvastatin in humans [SBT]identification of metabolizing enzymes and effect of the drug on hepatic P450s.
Prueksaritanont T; Gorham LM; Ma B; Liu L; Yu X; Zhao JJ; Slaughter DE; Arison BH; Vyas KP
Drug Metab Dispos; 1997 Oct; 25(10):1191-9. PubMed ID: 9321523
[TBL] [Abstract][Full Text] [Related]
18. Contribution of human cytochrome p-450 isoforms to the metabolism of the simplest phenothiazine neuroleptic promazine.
Wójcikowski J; Pichard-Garcia L; Maurel P; Daniel WA
Br J Pharmacol; 2003 Apr; 138(8):1465-74. PubMed ID: 12721102
[TBL] [Abstract][Full Text] [Related]
19. Roles of CYP3A4 and CYP2C19 in methyl hydroxylated and N-oxidized metabolite formation from voriconazole, a new anti-fungal agent, in human liver microsomes.
Murayama N; Imai N; Nakane T; Shimizu M; Yamazaki H
Biochem Pharmacol; 2007 Jun; 73(12):2020-6. PubMed ID: 17433262
[TBL] [Abstract][Full Text] [Related]
20. Inhibition and kinetics of cytochrome P4503A activity in microsomes from rat, human, and cdna-expressed human cytochrome P450.
Ghosal A; Satoh H; Thomas PE; Bush E; Moore D
Drug Metab Dispos; 1996 Sep; 24(9):940-7. PubMed ID: 8886602
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
